30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Whitfield Dianne C.

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
17 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Whitfield Dianne C.'s trades of Tarsus Pharmaceuticals, Inc.'s stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-19
S Sale
57,612 +37.4%
479.95
US$1,575,893 		57,612 +37.4% 479.95 US$1,575,893
2026-03-19 2026-03-19
PrS Proposed sale
54,572
222.15
US$86,946 		54,572 222.15 US$86,946
2026-03-19 2026-03-18
S Sale
5,928 +28.3%
184.55
US$2,612,033 		5,928 +28.3% 184.55 US$2,612,033
2026-03-18 2026-03-18
PrS Proposed sale
4,071
68.71
US$279,718 		4,071 68.71 US$279,718
2026-03-19 2026-03-17
S Sale
4,029 -8.5%
69.42
US$279,693 		4,029 -8.5% 69.42 US$279,693
2026-03-17 2026-03-17
PrS Proposed sale
4,029
69.41
US$279,672 		4,029 69.41 US$279,672
2026-01-06 2026-01-02
PlS Planned sale
893 -3.7%
82.93
US$74,056 		893 -3.7% 82.93 US$74,056
2026-01-06 2026-01-02
PlS Planned sale
835 -3.3%
81.90
US$68,386 		835 -3.3% 81.90 US$68,386
2026-01-06 2026-01-02
PlS Planned sale
8,122 -24.4%
80.71
US$655,527 		8,122 -24.4% 80.71 US$655,527
2026-01-06 2026-01-02
PlS Planned sale
5,715 -14.7%
80.09
US$457,714 		5,715 -14.7% 80.09 US$457,714
2026-01-02 2026-01-02
PrS Proposed sale
15,565
81.38
US$1,266,680 		15,565 81.38 US$1,266,680
2025-12-18 2025-12-16
PlS Planned sale
7,397 -16.0%
80.10
US$592,500 		7,397 -16.0% 80.10 US$592,500
2025-12-16 2025-12-16
PrS Proposed sale
7,397
80.10
US$592,500 		7,397 80.10 US$592,500
2025-03-20 2025-03-20
PrS Proposed sale
2,137
50.11
US$107,093 		2,137 50.11 US$107,093
2025-03-20 2025-03-20
S Sale
2,137 -4.4%
50.11
US$107,085 		2,137 -4.4% 50.11 US$107,085
2025-03-20 2025-03-19
S Sale
2,259 -4.5%
47.40
US$107,077 		2,259 -4.5% 47.40 US$107,077
2025-03-19 2025-03-19
PrS Proposed sale
2,259
47.40
US$107,075 		2,259 47.40 US$107,075
2025-03-20 2025-03-18
S Sale
2,315 -4.4%
46.29
US$107,161 		2,315 -4.4% 46.29 US$107,161
2025-03-18 2025-03-18
PrS Proposed sale
2,315
46.28
US$107,149 		2,315 46.28 US$107,149
2024-03-19 2024-03-18
S Sale
4,314 -11.2%
30.60
US$132,008 		4,314 -11.2% 30.60 US$132,008
2024-03-18 2024-03-18
PrS Proposed sale
4,314
30.60
US$131,998 		4,314 30.60 US$131,998
2023-12-01 2023-11-30
S Sale
8,355 -23.8%
16.31
US$136,270 		8,355 -23.8% 16.31 US$136,270
2023-11-30 2023-11-30
PrS Proposed sale
8,355
16.31
US$136,255 		8,355 16.31 US$136,255
2023-03-23 2023-03-23
S Sale
345 -3.0%
12.15
US$4,192 		345 -3.0% 12.15 US$4,192
2023-03-23 2023-03-22
S Sale
333 -2.8%
12.64
US$4,209 		333 -2.8% 12.64 US$4,209
2023-03-23 2023-03-21
S Sale
326 -2.7%
12.89
US$4,202 		326 -2.7% 12.89 US$4,202
2023-03-21 2023-03-20
S Sale
333 -2.7%
12.61
US$4,199 		333 -2.7% 12.61 US$4,199
2023-03-21 2023-03-17
S Sale
316 -2.5%
13.28
US$4,196 		316 -2.5% 13.28 US$4,196
2023-03-17 2023-03-16
S Sale
313 -2.4%
13.43
US$4,204 		313 -2.4% 13.43 US$4,204
2023-03-16 2023-03-16
PrS Proposed sale
2,015
13.66
US$27,525 		2,015 13.66 US$27,525
2022-12-06 2022-12-02
S Sale
1,154 -11.7%
16.90
US$19,503 		1,154 -11.7% 16.90 US$19,503
2022-12-01 2022-12-01
S Sale
1,165 -10.6%
16.75
US$19,514 		1,165 -10.6% 16.75 US$19,514
2022-12-01 2022-11-30
S Sale
1,182 -9.7%
16.50
US$19,503 		1,182 -9.7% 16.50 US$19,503